interesting comment !

This is part of a story dated, May 8, 2008


" Thoratec is redesigning its own next-generation device, called HeartMate III, to make it smaller, said Chief Executive Officer Gary Burbach in an interview. Burbach didn't say when it might be ready for human trials."

" Thoratec may supplement its pipeline by licensing or purchasing a new device, and rivals won't hurt Thoratec's revenue potential, he said."

All of it at:

http://www.bloomberg.com/apps/news?pid=newsarchive&sid=aImw1nInTWfA